Tag: Reddys
Browse our exclusive articles!
Dr Reddy’s Bachupally facility gets 5 observations from US FDA inspection
Dr Reddy’s Laboratories Ltd. has disclosed that the United States Food and Drug Administration (US FDA) issued it a Form 483 with five observations...
Dr. Reddy’s shares in focus after $50.5 million acquisition marking anti-vertigo foray
Hyderabad-based drugmaker Dr. Reddy's Laboratories has informed the bourses that it has entered into a definitive agreement with Janssen Pharmaceutica NV (JPNV), an affiliate...
Dr. Reddy’s, Aurobindo face a near-‘lost’ opportunity for an important pipeline drug; Here’s why
The US Food and Drug Administration (FDA) has granted approval to two generic versions of Iron Sucrose, developed by Viatris and Amphastar. According to...
Dr Reddy’s Q1 earnings may defy concerns around blockbuster cancer drug
Revlimid – the key concern for Dr Reddy’s is due to the drug’s patent expiry in January 2026, paving the way for competition from...
Dr Reddy’s recalls epilepsy drug in US over mislabeling concerns
Dr Reddy’s Laboratories has announced a nationwide recall of one batch of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) in the US...
